Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis

Objective. This review aimed at systematically evaluating the efficacy and safety of moxibustion for chronic fatigue syndrome (CFS). Methods. Relevant trials were searched in seven digital databases up to January 2021. After literature screening, data extraction, and literature quality evaluation, t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jianyu You, Jing Ye, Haiyan Li, Wenguo Ye, Ensi Hong
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/9590da2638a94a0bb55b7cc5f8888776
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9590da2638a94a0bb55b7cc5f8888776
record_format dspace
spelling oai:doaj.org-article:9590da2638a94a0bb55b7cc5f88887762021-11-22T01:10:47ZMoxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis1741-428810.1155/2021/6418217https://doaj.org/article/9590da2638a94a0bb55b7cc5f88887762021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/6418217https://doaj.org/toc/1741-4288Objective. This review aimed at systematically evaluating the efficacy and safety of moxibustion for chronic fatigue syndrome (CFS). Methods. Relevant trials were searched in seven digital databases up to January 2021. After literature screening, data extraction, and literature quality evaluation, the included studies were meta-analyzed using RevMan 5.4 software. The evidence level was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). Results. Fifteen studies involving 1030 CFS participants were included. Meta-analyses showed a favorable effect of moxibustion on the total effective rate compared with acupuncture (OR = 4.58, 95%CI = [2.85, 7.35], P<0.00001) and drugs (OR = 6.36, 95%CI = [3.48, 11.59], P<0.00001). Moxibustion also appeared to significantly reduce fatigue severity measured by fatigue scale-14 (FS-14) (WMD = −2.20, 95% CI = [−3.16, −1.24], P<0.00001) and fatigue assessment instrument (FAI) (WMD = −16.36, 95% CI = [−26.58, −6.14], P=0.002) compared with the control group. In addition, among the 15 included studies, only two studies reported adverse events related to moxibustion, and the symptoms were relatively mild. The quality of evidence based on the 15 included trials was assessed as moderate to very low. Conclusions. Based on limited evidence, moxibustion might be an effective and safe complementary therapy for CFS, which can be recommended to manage CFS. Because of the limited level of evidence in this review, further high-quality trials are still needed to confirm these findings.Jianyu YouJing YeHaiyan LiWenguo YeEnsi HongHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Other systems of medicine
RZ201-999
spellingShingle Other systems of medicine
RZ201-999
Jianyu You
Jing Ye
Haiyan Li
Wenguo Ye
Ensi Hong
Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
description Objective. This review aimed at systematically evaluating the efficacy and safety of moxibustion for chronic fatigue syndrome (CFS). Methods. Relevant trials were searched in seven digital databases up to January 2021. After literature screening, data extraction, and literature quality evaluation, the included studies were meta-analyzed using RevMan 5.4 software. The evidence level was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). Results. Fifteen studies involving 1030 CFS participants were included. Meta-analyses showed a favorable effect of moxibustion on the total effective rate compared with acupuncture (OR = 4.58, 95%CI = [2.85, 7.35], P<0.00001) and drugs (OR = 6.36, 95%CI = [3.48, 11.59], P<0.00001). Moxibustion also appeared to significantly reduce fatigue severity measured by fatigue scale-14 (FS-14) (WMD = −2.20, 95% CI = [−3.16, −1.24], P<0.00001) and fatigue assessment instrument (FAI) (WMD = −16.36, 95% CI = [−26.58, −6.14], P=0.002) compared with the control group. In addition, among the 15 included studies, only two studies reported adverse events related to moxibustion, and the symptoms were relatively mild. The quality of evidence based on the 15 included trials was assessed as moderate to very low. Conclusions. Based on limited evidence, moxibustion might be an effective and safe complementary therapy for CFS, which can be recommended to manage CFS. Because of the limited level of evidence in this review, further high-quality trials are still needed to confirm these findings.
format article
author Jianyu You
Jing Ye
Haiyan Li
Wenguo Ye
Ensi Hong
author_facet Jianyu You
Jing Ye
Haiyan Li
Wenguo Ye
Ensi Hong
author_sort Jianyu You
title Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
title_short Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
title_full Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
title_fullStr Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
title_full_unstemmed Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
title_sort moxibustion for chronic fatigue syndrome: a systematic review and meta-analysis
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/9590da2638a94a0bb55b7cc5f8888776
work_keys_str_mv AT jianyuyou moxibustionforchronicfatiguesyndromeasystematicreviewandmetaanalysis
AT jingye moxibustionforchronicfatiguesyndromeasystematicreviewandmetaanalysis
AT haiyanli moxibustionforchronicfatiguesyndromeasystematicreviewandmetaanalysis
AT wenguoye moxibustionforchronicfatiguesyndromeasystematicreviewandmetaanalysis
AT ensihong moxibustionforchronicfatiguesyndromeasystematicreviewandmetaanalysis
_version_ 1718418356347863040